Guardant Health (GH) Shares Outstanding (2017 - 2026)

Guardant Health has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $133.6 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 7.34% year-over-year to $133.6 million; the TTM figure through Jun 2026 stood at $133.6 million (up 7.34% YoY), while the FY2025 annual figure was $130.6 million, up 5.36% from the prior year.
• Shares Outstanding (Entity) came in at $133.6 million for Q2 2026 at Guardant Health, up from $131.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $133.6 million in Q2 2026 to a low of $101.9 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $118.3 million, with a median of $122.4 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) gained 0.78% in 2022 and advanced 18.58% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $102.6 million in 2022, then advanced by 18.53% to $121.6 million in 2023, then grew by 1.94% to $124.0 million in 2024, then rose by 5.36% to $130.6 million in 2025, then grew by 2.28% to $133.6 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $133.6 million in Q2 2026, $131.5 million in Q1 2026, and $130.6 million in Q4 2025.